The MedTech Pulse

The Pulse of Indian MedTech

Home » Sahajanand Medical Technologies
SMT’s Supraflex Cruz coronary stent shown against a European map and EU stars, highlighting its EU MDR clearance and global cardiovascular reach.
SMT’s Supraflex Cruz™ Stent receives a Health Canada Class IV Licence, highlighting the Indian MedTech company’s expansion into the Canadian market.

You missed

News

SMT’s Supraflex Cruz Clears Europe’s Toughest Device Law – Its Third Global Regulatory Win in a Single Year

Patient Education

Chronic Constipation: 7 Warning Signs That Mean It’s Time to See a Doctor

Cardiovascular

5 Next-Generation Cardiac Devices Being Developed and Used in India

Medtech

India’s Medical Device Market Hits $18 Billion — But the “45% Domestic” Number Deserves a Closer Look